Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-β and tumor necrosis factor-β

Blood

Volumn 87, Issue 12, 1996, Pages 5016-5026

  Jacobsen, Sten E W ^a   Veiby, Ole Retter ^b   Myklebust, June ^b   Okkenhaug, Cecilie ^b   Lyman, Stewart D ^b  

^a Cancer Prevention Institute Dayton   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NEUTRALIZING ANTIBODY; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 7; RECOMBINANT STEM CELL FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AGONIST; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL KINETICS; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENCY; DRUG POTENTIATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOPHENOTYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-11; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029992896     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5016.bloodjournal87125016     Document Type: Article

References (68)

1. Moore MAS: Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1, 1991
2. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
3. Metcalf D: Hematopoietic regulators: Redundancy or subtlety. Blood 82:3515, 1993
4. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis by the c-Mpl ligand. Nature 369:533, 1994
5. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, and Foster DC: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994
6. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571, 1994
7. Keller JR, Mantel C, Sing GK, Ellingsworth LR, Ruscetti SK, Ruscetti FW: Transforming growth factor β1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J Exp Med 168:737, 1988
8. Keller JR, Jacobsen SEW, Dubois CM, Hestdal K, Ruscetti FW: Transforming growth factor-β: A bidirectional regulator of hematopoietic cell growth. Int J Cell Cloning 10:2, 1992.
9. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY: The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-γ. J Immunol 136:4487, 1986
10. Broxmeyer HE, Sherry B, Lu L, Cooper S, Carow C, Wolpe SD, Cerami A: Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells. J Exp Med 170:1583, 1989
11. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB: Identification and characterization of an inhibitor of hematopoietic stem cell proliferation. Nature 344:442, 1990
12. Keller JR, Jacobsen SEW, Sill KT, Ellingsworth LR, Ruscetti FW: Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte/macrophage-colony-stimulating factor. Proc Natl Acad Sci USA 88:7190, 1991
13. + hematopoietic progenitor cells. Blood 75:2292, 1990
14. + hematopoietic progenitor cells. Blood 79:2628, 1992
15. Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit proto-oncogene. Cell 63:167, 1990
16. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Satyagal VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE: Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195, 1990
17. Huang E, Nocka K, Beier D, Chu T-U, Buch J, Lahm H-W, Wellner D, Leder P, Besmer P. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225, 1990
18. Galli SJ, KM Zsebo, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1, 1994
19. Heyworth CM, Whetton AD, Nicholls S, Zsebo K, Dexter TM: Stem cell factor directly stimulates the development of enriched granulocyte-macrophage colony-forming cells and promotes the effects of other colony-stimulating factors. Blood 80:2230, 1992
20. de Vries P, Brasel KA, Eisenman JR, Alpert AR, Williams DE: The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med 173:1205, 1991
21. Metcalf D, Nicola NA: Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: Effects of combination with colony-stimulating factors. Proc Natl Acad Sci USA 88:6239, 1991
22. Migliaccio G, Migliaccio AR, Valinsky J, Langley K, Zsebo K, Visser JWM, Adamson JW: Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci USA 88:7420, 1991
23. Tsuji K, Zsebo KM, Ogawa M: Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit. Blood 78:1223, 1991
24. Williams N, Bertoncello I, Kavnoudias H, Zsebo K, McNiece I: Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations. Blood 79:58, 1992
25. Jacobsen SEW, Veiby OP, Smeland EB: Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J Exp Med 178:413, 1993
26. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A: The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88, 1988
27. Geissler EN, Ryan MA, Housman DE: The dominant-white spotting (W) locus of the mice encodes the c-kit proto-oncogene. Cell 55:185, 1988
28. Sherr CJ, Rettenmeier CW, Sacca R, Roussel MF, Look AT, Stanley ER: The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665, 1985
29. Rosnet O, Marchetto S, deLapeyriere E, Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/ CSF-1R family. Oncogene 6:1641, 1991
30. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143, 1991
31. Zeigler FC, Bennett BD, Jordan CT, Spencer SD, Baumheuter S, Carrol KJ, Hooley J, Bauer K, Matthews W: Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84:2422, 1994
32. Lyman SD, James L, Bos TV, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckman MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
33. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
34. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
35. Jacobsen SEW, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The flt3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
36. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes LA, Rennick D: Flt3/flk2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747, 1995
37. Hirayama F, Lyman SD, Clark SC, Ogawa M: The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood 85:1762, 1995
38. McNiece IK, Bertoncello I, Keller JR, Ruscetti FW, Hatley CA, Zsebo KM: Transforming growth factor β inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int J Cell Cloning 10:80, 1992
39. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Krönke M, Mak TW: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shoch, yet succumb to L monocytogenes infection. Cell 73:457, 1993
40. Rothe J, Lesslauer W, Lötscher H, Lang Y, Koebel P, Köntgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798, 1993
41. Balkwill FR: Tumor necrosis factor and cancer. Prog Growth Factor Res 4:121, 1992
42. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami AC: Anti-cachectin/TNF monoklonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662, 1987
43. Jacob CO: Tumor necrosis factor a in autoimmunity: Pretty girl or old witch? Immunol Today 13:122, 1992
44. Means RT, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639, 1992
45. Backx B, Broeders L, Bot FJ, Löwenberg B: Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors. Leukemia 5:66, 1990
46. + progenitors. J Exp Med 177:1815, 1993
47. Rusten LS, Jacobsen FW, Lesslauer W, Loetscher H, Smeland EB, Jacobsen SEW: Bifunctional effects of TNF-α on the growth of mature and primitive human hematopoietic progenitor cells: Involvement of p55 and p75 TNF receptors. Blood 83:3152, 1994
48. Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetscher H, Dubois CM, Jacobsen SEW: TNF-α inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro: Role of p55 and p75 TNF receptors. J Clin Invest 94:165, 1994
49. Jacobsen FW, Rothe M, Rusten L, Goeddel DV, Smeland EB, Veiby OP, Slørdal L, Jacobsen SEW: Role of the 75-kDa tumor necrosis factor (TNF) receptor: Inhibition of early hematopoiesis. Proc Natl Acad Sci USA 91:10695, 1994
50. Brach MA, Buhring H-J, Gruss H-J, Ashman LK, Ludwig W-D, Mertelsmann RH, Herrmann F: Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-α through posttranscriptional mRNA stabilization by a labile protein. Blood 80:1224, 1992
51. Loetscher H, Pan YE, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W: Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351, 1990
52. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV: Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361, 1990
53. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019, 1990
54. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV: Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830, 1991
55. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 13:151, 1992
56. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292, 1991
57. Spangrude GJ, Heimfield S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
58. Spangrude GJ, Scollay R: A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol 18:920, 1990
59. Hatzfeld J, Li M-L, Brown EL, Sookeda H, Levesque J-P, O'Toole T, Gurney C, Clark SC, Hatzfeld A: Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. J Exp Med 174:925, 1991
60. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
61. + human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp Hematol 22:903, 1994
62. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
63. Mackarechtschian K, Hardin JF, Moore KA, Boast S, Goff SP, Lemischka: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995
64. Ploemacher RE, van Soest PL, Boudewijn A: Autocrine transforming growth factor β1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor. Stem Cells 11:336, 1993
65. Tartaglia LA, Pennica D, Goeddel DV: Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542, 1993
66. Barbara JAJ, Smith WB, Gamble JR, van Ostade X, Vandenabeele P, Tavernier J, Fiers W, Vadas JA, Lopez AF: Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMBO J 13:843, 1994
67. Topal K, LaPushin R, Kohno T, Darnay BG, Aggarwal BB: TNF and its receptor antibody differ in mediation of cellular responses. J Immunol 153:2248, 1994
68. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793, 1995